PH-sensitive tumor targeted recombinant high-density lipoprotein as well as preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- XUZHOU MEDICAL UNIV
- Publication Date
- 2019-04-05
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and in particular relates to a pH-sensitive tumor-targeting recombinant high-density lipoprotein and a preparation method. Background technique
[0002] At present, anti-tumor drugs, especially fat-soluble anti-tumor drugs, generally have problems such as low bioavailability and low tumor killing selectivity, for example, paclitaxel and doxorubicin, although they have good anti-tumor activity, their solubility in water is low (<0.03g / L), wide range of action, weak specificity, strong toxic and side effects, so its oral preparations and injections have encountered problems such as low bioavailability and low tumor killing selectivity in clinical application, so clinical treatment There is an urgent need for an effective method to improve the solubility of fat-soluble antineoplastic drugs, reduce the toxic and side effects of antineoplastic drugs, and increase the tumor killing effect of antine...